Director, Medical Science Liaison, Oncology (ND, SD, NE, MO, IA, KS)

Das ist der Job

Location This role covers North Dakota, South Dakota, Nebraska, Missouri, Iowa and Kansas.

Darum lohnt es sich

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison.

Key aspects of this role will include engaging in peer‑to‑peer scientific dialogue with healthcare professionals that translate into meaningful insights, serving as a therapeutic expert and thought partner to internal teams, acting as liaison between Revolution Medicines and clinical study sites/investigators, and providing support for medical education, advisory boards and medical congresses.

Key Responsibilities • Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge. • Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions. • Support the synthesis and communicate scientific insights from KOLs to relevant internal teams. • Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities. • Establish credibility as a scientific expert and resource for internal stakeholders, providing medical and scientific support for products and therapeutic areas. • Collaborate cross‑functionally with medical affairs, clinical development, marketing and other teams to support the development and execution of medical strategies and tactics. • Stay current with scientific literature, emerging research, and competitive landscape. • Adhere to Revolution Medicines Core Values and policies. • Understand the regulatory requirements for customer engagement by field‑based employees.

Base pay salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

The amount and availability of any bonus, commission, incentive, field kit benefits, or any other form of compensation and field kit benefits that are allocable to a particular employee remains in the Company’s sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.

If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to so we can share these impersonations with our IT team for tracking and awareness.

Company Overview Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC‑6291), a RAS(ON) G12C‑selective inhibitor; zoldonrasib (RMC‑9805), a RAS(ON) G12D‑selective inhibitor; and RMC‑5127, a RAS(ON) G12V‑selective inhibitor, are currently in clinical development.

Required Skills, Experience and Education • Doctoral degree in scientific or medical discipline. • 8+ years experience as an MSL or in a similar role within the pharmaceutical or biotech industry. • 3+ years experience as a MSL working in the lung cancer disease state area. • Strong understanding of clinical research methodologies and drug development processes. • Knowledge and experience within the oncology therapeutic area. • Excellent verbal and written communication skills. • Proven ability to analyze and synthesize scientific information effectively. • Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences. • Strong networking skills with proven ability to successfully build and maintain relationships with KOLs and healthcare professionals. • Self‑directed and able to thrive in a fast‑paced and dynamic environment. • Willingness to travel up to 60% of time.

Preferred Skills • Preferred experience in lung and gastrointestinal cancers. • Experience with both early and late stage clinical assets as well as approved therapies. The candidate should be located within an hour drive of a major airport. Compensation The base pay salary range for this full‑time position is $236,000—$259,000 USD.

Some positions may include eligibility to earn commissions/bonus based on company and/or individual performance. Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable.

Equal Opportunity Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.

Data Privacy Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy.

For additional information, please contact Important Notice About Recruitment Scams We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines.

These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.